Molecular Pharmaceutics
[ASAP] Latanoprost-Loaded Nanotransfersomes Designed for Scalp Administration Enhance Keratinocytes Proliferation
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00796
Molecular Pharmaceutics
[ASAP] Rational Understanding of Loading and Release of Doxorubicin by UV-Light- and pH-Responsive Poly(NIPAM-<italic toggle=”yes”>co</italic>-SPMA) Micelle-like Aggregates
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00690
Molecular Pharmaceutics
[ASAP] Synergistic Effect Evaluation of Magnetotherapy and a Cationic–Magnetic Nanocomposite Loaded with Doxorubicin for Targeted Drug Delivery to Breast Adenocarcinoma
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00505
Molecular Pharmaceutics
[ASAP] Caffeic Acid-Conjugated Budesonide-Loaded Nanomicelle Attenuates Inflammation in Experimental Colitis
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00558
Molecular Pharmaceutics
[ASAP] Predicting the Pharmacokinetics of Orally Administered Drugs across BCS Classes 1–4 by Virtual Bioequivalence Model
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00688
Molecular Pharmaceutics
[ASAP] Multicomponent Chiral Quantification with Ultraviolet Circular Dichroism Spectroscopy: Ternary and Quaternary Phase Diagrams of Levetiracetam
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00825
Molecular Pharmaceutics
[ASAP] Advanced Therapies for Traumatic Central Nervous System Injury: Delivery Strategy Reinforced Efficient Microglial Manipulation
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00605
Molecular Pharmaceutics
[ASAP] Nafamostat Mesylate in Combination with the Mouse Amino-Terminal Fragment of Urokinase–Human Serum Albumin Improves the Treatment Outcome of Triple-Negative Breast Cancer Therapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00297
Molecular Pharmaceutics
[ASAP] Development of In Silico Models for Predicting Potential Time-Dependent Inhibitors of Cytochrome P450 3A4
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00571
Molecular Pharmaceutics
[ASAP] Synthesis of Novel Pentacyclic Triterpenoid Derivatives that Induce Apoptosis in Cancer Cells through a ROS-dependent, Mitochondrial-Mediated Pathway
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00885